The healthcare industry is currently undergoing a paradigm shift from "reactive" treatment to "proactive" precision medicine. Central to this evolution is the Biomarker Technologies Market which provides the essential tools to identify biological signatures of health and disease at the molecular level. As we move into 2025, these technologies are no longer confined to academic researc... https://www.databridgemarketresearch.com/